Miguel Segura

29PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisMedical molecular engineering of nucleic acids and proteinsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 25, 2026
Impact of Metastatic Patterns on Survival and Response to Therapy in Neuroblastoma.

|Aug 25, 2025
Epigenetic synthetic lethality as a cancer therapeutic strategy: synergy of experimental and computational approaches.

Maria Farina-Morillas, Laia Ollé-Monràs, Silvana Ce Maas

|Mar 28, 2025
BORA overexpression promotes epithelial-mesenchymal transition and metastasis in ovarian cancer: Unveiling a novel therapeutic target for advanced disease.

Marta Barber, Ariadna Boloix, Alfonso Parrilla

|Sep 11, 2024
Advances in the approaches used to repurpose drugs for neuroblastoma.

Marta Miera-Maluenda, María Pérez-Torres, Adriana Mañas

|May 29, 2024
In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.

Catherine Murphy, Laura Devis-Jauregui, Ronja Struck

|Apr 09, 2024
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis.

Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez-Rivera

Pageof 5

Frequent Collaborators

8 joint publications

Soledad Gallego

8 joint publications

Aroa Soriano Fernandez

7 joint publications

Josep Roma

7 joint publications

Lucas Moreno